Title 21 published on 2013-04-01
no entries appear in the Federal Register after this date.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
§ 321 - Definitions; generally
§ 331 - Prohibited acts
§ 351 - Adulterated drugs and devices
§ 352 - Misbranded drugs and devices
§ 355 - New drugs
§ 360 - Registration of producers of drugs or devices
§ 360c - Classification of devices intended for human use
§ 360e - Premarket approval
§ 360aa - Recommendations for investigations of drugs for rare diseases or conditions
§ 360bb - Designation of drugs for rare diseases or conditions
§ 360cc - Protection for drugs for rare diseases or conditions
§ 360dd - Open protocols for investigations of drugs for rare diseases or conditions
§ 360ee - Grants and contracts for development of drugs for rare diseases and conditions
§ 360hh - Definitions
§ 360ii - Program of control
§ 360jj - Studies by Secretary
§ 360kk - Performance standards for electronic products
21 USC § -
§ 360mm - Imports
§ 360nn - Inspection, records, and reports
§ 360pp - Enforcement
§ 360qq - Repealed.
§ 360rr - Federal-State cooperation
§ 360ss - State standards
21 USC § 360aaa to 360aaa–6 - Omitted
§ 371 - Regulations and hearings
§ 374 - Inspection
§ 262 - Regulation of biological products